HOME › DRUGS › NAXITAMAB-GQGK
ACTIVE SUBSTANCE / INN

NAXITAMAB-GQGK

Brand name(s): DANYELZA
FDA LISTED
PRESCRIPTION
BLA761171
ACTIVE SUBSTANCE
Naxitamab-Gqgk
REGULATORS
FDA
SPONSORS / MAH
Y-MABS THERAPEUTICS INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DANYELZABLA761171Y-MABS THERAPEUTICS INCPrescription

FULL INTELLIGENCE ON NAXITAMAB-GQGK

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →